Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic effect of ADP receptor inhibitor added to aspirin in hypercoagulable patients undergoing CABG surgery
2007-003218-33Phase 2Completed
- Sponsor
- Blodbanken, Rigshospitalet
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clopidogrel in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by Blodbanken, Rigshospitalet. Primary endpoints: Graft patency at 3 months and Ischemic events within 6 months. Started Jul 2007; status: completed.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-003218-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003218-33.